Ana Pereira, MD
-
- Positions
- ASSOCIATE PROFESSOR | Neurology
- ASSOCIATE PROFESSOR | Neuroscience
-
- Specialty
- Neurology
-
- Languages
- English
- Portuguese
- French
- Spanish
-
- Hospital Affiliation
- The Mount Sinai Hospital
-
- Phone
- Center for Cognitive Health 212-241-7076 212-241-7076
-
Center for Cognitive Health
5 East 98th St
7th Floor
New York, NY 10029
Phone: 212-241-7076212-241-7076
Certification
Neurology, American Board of Psychiatry and Neurology
Clinical Focus
- Alzheimer's Disease
- Dementia
- Frontal Lobe Dementia
- Lewy Body Disease
- Memory Disorder
Research Topic
Alzheimer's Disease, Cognitive Neurology, Cognitive Neuroscience
Multi-Disciplinary Training Area
Neuroscience [NEU]
Education
MD, Universidade Federal de Sao Paulo
MS, Translational and Clinical Investigation, Rockefeller University
Internship, Internal Medicine
Albert Einstein College of Medicine
Residency, Neurology
Harvard Medical School
Fellowship, Cognitive Neurology
Columbia University
Languages
English, Portuguese, French, Spanish
2021
Project Award
The Sanford Grossman Interdisciplinary Program in Neural Circuitry and Immune Function at ISMMS
2021
Medical Research Award
Robert J. and Claire Pasarow Foundation
2020
R01 Award
National Institutes of Health
Mechanisms of Susceptibility of Excitatory Neurons to Tau Pathology and Neurodegeneration in Alzheimer’s disease
2019
R01 Award
National Institutes of Health
Mechanisms of Obstructive Sleep Apnea in Tau Pathophysiology, Risk and Progression of Alzheimer’s Disease
2018
Alzheimer’s Association Research Grant Award
2017
Robertson Therapeutic Development Award
2016
Dana Foundation Award Recipient
2016
BrightFocus Award Recipient
2016
Bernard L. Schwartz Award for Physician Scientists
2016
NIH Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76)
2015
Young Investigator Award by the Alzheimer’s Drug Discovery Foundation
2015
Rockefeller University Pilot Project Award Recipient
2013
Alzheimer’s Drug Discovery Foundation Awarded Grant
2013
Appointed Chief Clinical Scholar at the Rockefeller University
2013
CTSA Pilot Project Award Recipient
2012
Diplomate of the American Board of Psychiatry and Neurology
2012
Rockefeller University Pilot Award Recipient
2012
Dana Foundation Award Recipient
2011
CTSA Pilot Project Award Recipient
Translational and Clinical Studies
In parallel, as a physician-scientist, Dr. Pereira has been conducting translational and clinical studies using state-of-the-art neuroimaging and neuropsychological measures, including a clinical trial for a potential novel therapeutic intervention for patients with Alzheimer’s disease. More details at Pereira Lab website https://labs.icahn.mssm.edu/pereiralab/
Glutamatergic Neuronal Susceptibility
Dr. Pereira and her lab members have been studying glutamatergic neuronal susceptibility with modern quantitative cell biology methods in conjunction with molecular tools and functional assays. More details at Pereira Lab website https://labs.icahn.mssm.edu/pereiralab/
Risk Factors for Alzheimer's Disease
Pereira Lab has also been investigating risk factors for Alzheimer’s disease, such as intermittent hypoxia that occurs in sleep-disordered breathing and its mechanisms. These studies aim to develop novel preventive measures and therapeutic targets for age-related cognitive decline and Alzheimer’s disease. More details at Pereira Lab website https://labs.icahn.mssm.edu/pereiralab/
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Pereira during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Company Founder:
- Patent applications
- Patent applications - same
Royalty Payments:
- lisended to Neurobiopharma, LLC. No payments or royalties have been received so far
- will be licensed to Neurobiopharma, LLC (no royalties or payments have been made yet)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.